From: Stetler-Stevenson, Maryalice (NIH/NCI) (stetler@mail.nih.gov)
Date: Wed Oct 01 2003 - 12:32:03 EST
The Clinical Cytometry Society's 18th Annual Meeting is in Arlington, Virginia (10 minutes from Ronald Regan Airport, Washington, DC). When: November 8-10, 2003 There are Research and Clinical Sessions Research Sessions: Antibody Based Therapy and Quantitative Flow Chairs Maryalice Stetler-Stevenson, M.D.Ph.D. and Gerald Marti, M.D.Ph.D. 1. Phase I Study of Combination Rituximab (CD20) and Apolizumab (Hu1D10) Monoclonal Antibody Therapy in Previously Treated B-cell Lymphoma and Chronic Lymphocytic Leukemia, Wyndham Wilson, M.D. Ph.D., NCI, NIH 2. Receptor-directed Therapy of Adult T-cell Leukemia/Lymphoma, John C. Morris, M.D. 3. Rituximab Induced CD 20 Down Modulation and Effects of Campath on CD52, Maher Albitar, M.D. 4. Emergence of Clinical Quantitative Flow Cytometry (QFCM), Gerald E. Marti, M.D. Ph.D. HIV Research and Technical Aspects Chairs: Maria Arroz, M.D. and Frank Mandy, Ph.D. 1. Monitoring HIV therapy in HIV reservoirs (Cell-Reservoir Specific Anti-retroviral Therapy), Bruce Patterson, M.D. 2. The T-cells that harbour HIV in vivo: implications for pathogenesis, Daniel Douek, M.D. Ph.D. 3. Strategies to restore Immune Control of HIV, Brigite Autran, M.D. Ph.D. 4. International efforts to make CD4 T-cell enumeration affordable: Where they are needed the most, George Janossy, M.D. Ph.D. 5. Update on CD4 T-cell guidelines, Frank Mandy, Ph.D. Fast Forward Flow: Emerging technologies and procedures in Flow Cytometry Chairs: Mara Neal Ends, MT, SH(ASCP), MS, MBA., and Lawrence S. Lamb, Ph.D. 1. The Use of MHC Tetramers In Flow Cytometry, Stephen T Haley, Ph.D. 2. The Natural Killer Cells as Immunotherapy of Leukemia, Andrea Velardi, M.D. 3. Cell signaling by flow: New tools for research and the clinic, Brad Smith, Ph.D. 4. Autoimmune Lymphoproliferative Syndrome (ALPS): A Problem in the Fas Lane, Thomas A Fleisher, M.D. 5. Monocyte I.C. Cytokine Flow Cytometry: Association With Acute GVHD and Immune Activation After Allogeneic Hematopoietic Stem Cell Transplantation, Daniel Fowler, Frontiers in Clinical Flow Cytometry Chairs: Maryalice Stetler-Stevenson, M.D.Ph.D. and Phil McCoy, Ph.D. 1. Anti-Angiogenesis Agents in Clinical Trials: Monitoring and Surrogate End Points, Steven Libutti, M.D. 2. Examining the Role of the Immune System in Eradicating PNH Through Non-Myeloablative Allogeneic Stem Cell Transplantation, Richard Childs, M.D. 3. Development of Vaccines and Therapeutics for Ebola Virus, Nancy J. Sullivan, Ph.D. Clinical Session: Survival Tactics in Clinical Flow Cytometry Teri Oldaker, C.L.S. and Elizabeth Stone, M.T. 1. Preparing for a CAP inspection, John Carey, M.D. 2. The Basics of Quality Control in Clinical Flow, Norman Purvis, Ph.D. 3. European Quality Assurance, David Barnett, Ph.D. 4. Cytoplasmic/Nuclear staining, Carleton Stewart, Ph.D. 5. Tissue processing procedures for Lymphomas, Connstance Yuan, M.D.Ph.D. 6. Flow approaches to MRD, Carleton Stewart, Ph.D. Educational Sessions: Luncheon Workshops 1. Flow Cytometric Testing in ALL Joseph A. DiGiuseppe, M.D. Ph.D. 2. Flow Cytometric Testing in AML Jeannine Holden, M.D. 3. Lymphoma Raul Braylan, M.D. 4. Standardization Teri Oldaker, B.S. 5. Phenotypic diagnosis of T- and B-cell clonality Alberto Orfao, M.D.Ph.D. 6. Functional Flow Cytometry Assays Maurice O'Gorman, Ph.D. 7. Flow Cytometric Testing for PNH Brent Wood, M.D.Ph.D. 8. Flow Cytometric Bead-Based Assays Frank Mandy, Ph.D. Special Leukemia and Lymphoma Workshop EASY WAYS TO REGISTER Tel - 719-590-1620 Mon through Fri - 8:30 am - 5:00 pm MST Fax - 719-590-1619 or Mail: CCS, P.O. Box 25456, Colorado Springs, CO 80936-5456 Overnight: CCS, 5832 Poudre Way. Colorado Springs, CO 80922. Online: www.cytometry.org Maryalice Stetler-Stevenson Chief, Flow Cytometry Unit Laboratory of Pathology, NCI, NIH Sometimes you're the windshield, sometimes you're the bug.
This archive was generated by hypermail 2.1.6 : Thu Jan 01 2004 - 17:43:57 EST
